Contacts
+1 626 345 8596
Call us: +1 626 345 8596

Precision Medicine Assays

A complete solution to assess heart disease risk.

How it works:

Kit sent at home or wellness clinic
Sample collected with shoulder patch and proprietary device
Barcoded sample is sterile & stable at room temperature
Vial is mailed to Proteas Health lab via prepaid label
Sample analyzed using patented nanotechnology facilitated mass spectrometry
Results are communicated via a HIPAA compliant app to individual
Or to the healthcare provider

A 300-protein targeted plasma assay

Examines 7 molecular processes implicated in the development of coronary artery disease

      1. Obesity | Lipid Metabolism
      2. Diabetes | Sugar Metabolism
      3. Atherosclerosis | Plaque Formation
      4. Aging | Oxidative Stress
      5. Stress | Inflammation
      6. Hypertension | High Blood Pressure
      7. Thrombosis | Clot Formation

The results show risk of coronary artery stenosis due to atheromatous plaque

heart-risk1

Low risk

0-20% stenosis in coronary arteries
Repeat test in 12 months

heart-risk2

Medium risk

20-50% stenosis in coronary arteries
Consult with cardiologist
Proteas Nutritionist offers diet advice
Repeat test in 6 months

heart-risk3

High risk

50% stenosis in coronary arteries
Consult with cardiologist
Proteas Nutritionist offers diet advice
Repeat test in 6 months

Developed using in-house generated proteomic databases from patients with verified heart disease.
A 300-protein panel, monitors these 7 processes that contribute to heart disease:
Obesity | Lipid Metabolism
Diabetes | Metabolism
Atherosclerosis |
Plaque Formation
Aging | Oxidative Stress
Stress | Inflammation
Vascular Wall pathology |
High Blood Pressure
Thrombosis | Clot formation
Heart Disease Risk Assessment

HeartBiT™️ Endorsed by Top Cardiologists

The unique aspect of the HeartBiT™️ blood test is its ability to holistically monitor multiple molecular processes that participate in the initiation and progression of heart disease with a single assay. Furthermore, the HeartBiT ™️, thanks to this unique capability, can provide a more precision medicine guidance to allow a cardiologist to implement an individualized and thus more effective approach in treating patients. Our on-going collaboration is intended, in part, to further validate and substantiate Proteas’ HeartBiT ™️ plasma fluid assessment.
Matthew Budoff, MD
Professor of Medicine, David Geffen School of Medicine at UCLA Program Director and Director of Cardiac CT, Division of Cardiology, Harbor-UCLA Medical Center